Drug intelligence / Profile preview

gentamicin-collagen sponge + levofloxacin

Development stage
Unknown
Lead developer
Geistlich Pharma
Modality
Small Molecules
Administration
Topical, Oral, Intravenous
01

Overview

The combination of a gentamicin-collagen sponge and levofloxacin is used as an adjunctive therapy for the treatment of infected skin ulcers, particularly in diabetic foot infections. The gentamicin-collagen sponge is a topical device made from bovine collagen impregnated with the aminoglycoside antibiotic gentamicin. When applied to wounds, the collagen matrix gradually breaks down, releasing high local concentrations of gentamicin directly into the ulcer site with minimal systemic absorption. Gentamicin acts by binding to bacterial 16S rRNA in the 30S ribosomal subunit, disrupting protein synthesis and causing bacterial cell death. Levofloxacin is a systemic fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and cell division, leading to bactericidal activity[6][7]. This combination aims to enhance infection control by providing both local (gentamicin) and systemic (levofloxacin) antibacterial effects. Clinical studies have evaluated this approach primarily in moderate or mild diabetic foot infections; results suggest potential benefits in pathogen eradication rates and clinical cure when compared to standard care alone[1][2][3].

02

Targets

16S rRNA (16S ribosomal RNA)Topo IV (Bacterial Topoisomerase IV)DNA gyrase

Beyond the preview

Go deeper on gentamicin-collagen sponge + levofloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gentamicin-collagen sponge + levofloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call